In the BioHarmony Drug Report Database

"Preview" Icon

Pegaspargase

Oncaspar (pegaspargase) is an enzyme pharmaceutical. Pegaspargase was first approved as Oncaspar on 1994-02-01. It is used to treat b-cell chronic lymphocytic leukemia, blast crisis, non-hodgkin lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat precursor cell lymphoblastic leukemia-lymphoma.

 

Trade Name

 

Oncaspar
 

Common Name

 

pegaspargase
 

ChEMBL ID

 

CHEMBL2108546
 

Indication

 

b-cell chronic lymphocytic leukemia, blast crisis, non-hodgkin lymphoma, precursor cell lymphoblastic leukemia-lymphoma
 

Drug Class

 

Enzymes; PEGylated compounds

Image (chem structure or protein)

Pegaspargase structure rendering